Company research / AXSM
Axsome Therapeutics, Inc. (AXSM)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Axsome Therapeutics, Inc. reported revenue of $638.50M. Revenue grew 65.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $776.57M.
Key ratios (year ended 2025-12-31)
-26.1%
Operating margin
-28.7%
Net margin
-207.5%
Return on year-end equity
65.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.